(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Struktur
110548-07-7
CAS-Nr.
110548-07-7
Englisch Name:
(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Synonyma:
Levofloxacin-12;Levofloacin Impurity L;(R)-Ofloxacin Carboxylic Acid;(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;(R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3R)-;Levofloxacin impurity 14/(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
CBNumber:
CB33110770
Summenformel:
C13H9F2NO4
Molgewicht:
281.21
MOL-Datei:
110548-07-7.mol

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Eigenschaften

Siedepunkt:
459.2±45.0 °C(Predicted)
Dichte
1.61±0.1 g/cm3(Predicted)
pka
4.87±0.40(Predicted)

Sicherheit

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

The R-enantiomer of Levofloxacin Carboxylic Acid (L360250); an impurity of Levofloxacin. The (S)-enantiomer is substantially the more active.

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 50)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Shanghai Payne Pharmaceutical Technology Co.Ltd
021-58123769 18678586262
info@paynepharm.com China 1354 58
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4791 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17995 56
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
sales@reading-chemicals.com China 15185 58
Nanjing XiZe Biotechnology CO., Ltd. 025-58362220 15250997978
1511893459@qq.com China 7774 55
BOC Sciences 16314854226
info@bocsci.com United States 9926 65

110548-07-7()Verwandte Suche:


  • (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • (R)-Ofloxacin Carboxylic Acid
  • Levofloxacin-12
  • Levofloxacin impurity 14/(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • (R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
  • Levofloacin Impurity L
  • 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3R)-
  • 110548-07-7
Copyright 2019 © ChemicalBook. All rights reserved